Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (SHA:688621)
China flag China · Delayed Price · Currency is CNY
65.26
+1.75 (2.76%)
Feb 3, 2026, 3:00 PM CST

SHA:688621 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
571.41565.56690.93608.93490.25109.31
Short-Term Investments
-20----
Trading Asset Securities
135303013.11157.6-
Cash & Short-Term Investments
706.41615.56720.93622.04647.85109.31
Cash Growth
1.75%-14.62%15.90%-3.98%492.70%42.90%
Accounts Receivable
832.89774.96555.83362.73239.2112.78
Other Receivables
9.2410.1611.2116.17122.37
Receivables
842.12785.12567.04378.9251.21115.15
Inventory
14.115.0514.4112.547.846.29
Prepaid Expenses
----1.9-
Other Current Assets
187.4798.7654.7626.4832.9932.13
Total Current Assets
1,7501,5141,3571,040941.79262.87
Property, Plant & Equipment
179.81211.61220.26197.02161.0574.64
Long-Term Investments
56.06115.69100.7594.7540-
Goodwill
26.0626.0626.0626.0626.0626.06
Other Intangible Assets
4.585.415.394.23.324.04
Long-Term Deferred Tax Assets
88.6664.0438.9316.695.032.65
Long-Term Deferred Charges
34.9648.2864.1976.2533.4113.16
Other Long-Term Assets
70.71.7350.318.7831.991.43
Total Assets
2,2111,9871,8631,4641,243384.86
Accounts Payable
43.87.317.8322.1312.529.55
Accrued Expenses
22.1377.2488.7237.2927.3322.51
Short-Term Debt
481309.39383.93201.17138.0123.5
Current Portion of Long-Term Debt
41.4719.3----
Current Portion of Leases
-24.7822.122.5418.98-
Current Income Taxes Payable
34.386.624.9216.9311.422.82
Current Unearned Revenue
339.32321.43220.83205.85199.85128.29
Other Current Liabilities
12.6812.5112.8812.279.725.27
Total Current Liabilities
974.78778.56761.21518.19417.83191.94
Long-Term Debt
4867.2----
Long-Term Leases
17.9535.1240.6233.8449.72-
Long-Term Unearned Revenue
3.662.523.592.835.46-
Long-Term Deferred Tax Liabilities
0.061.250.350.24--
Total Liabilities
1,046884.65805.76555.1473.01191.94
Common Stock
112112112808060
Additional Paid-In Capital
391.97375.86474.17499.85499.8552.66
Retained Earnings
758.25612.78453.85317.09182.176.44
Total Common Equity
1,1621,1011,040896.93761.95189.1
Minority Interest
32.0117.2511.677.693.81
Shareholders' Equity
1,1651,1031,057908.6769.64192.92
Total Liabilities & Equity
2,2111,9871,8631,4641,243384.86
Total Debt
588.42455.79446.65257.55206.7123.5
Net Cash (Debt)
117.99159.77274.28364.48441.1485.81
Net Cash Growth
-39.27%-41.75%-24.75%-17.38%414.12%33.05%
Net Cash Per Share
1.071.422.453.264.501.02
Filing Date Shares Outstanding
109.2811211211211284
Total Common Shares Outstanding
109.2811211211211284
Working Capital
775.33735.93595.93521.77523.9670.94
Book Value Per Share
10.649.839.298.016.802.25
Tangible Book Value
1,1321,0691,009866.68732.57159.01
Tangible Book Value Per Share
10.369.559.017.746.541.89
Machinery
-256.34232.62195.9124.14101.1
Construction In Progress
----3.4-
Order Backlog
-3,273----
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.